Loading…
Lobbying Spend
—
Filings
18
Firms Hired
1
Active Period
2014–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Issues related to cybersecurity of medical devices manufactured in China. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Policies impacting third party repair of medtech. Issues related to competitive bidding in the FY2027 National Defense Authorization Act (H.R.8800/S.4784).
Client expense: — · Firm income: $50,000
Matched citations: H.R.8800
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Discussions regarding implementation of medtech related provisions; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.9260
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Policies impacting third party repair of medtech. Issues related to competitive bidding in the FY2027 National Defense Authorization Act (H.R.8800/S.4784).
Client expense: — · Firm income: $50,000
Matched citations: S.4784
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Issues related to cybersecurity of medical devices manufactured in China. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
National Defense Authorization Act for Fiscal Year 2027
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Policies impacting third party repair of medtech. Issues related to competitive bidding in the FY2027 National Defense Authorization Act (H.R.8800/S.4784).
Client expense: — · Firm income: $50,000
Matched citations: H.R.8800
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Discussions regarding implementation of medtech related provisions; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.9260
National Defense Authorization Act for Fiscal Year 2027
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Policies impacting third party repair of medtech. Issues related to competitive bidding in the FY2027 National Defense Authorization Act (H.R.8800/S.4784).
Client expense: — · Firm income: $50,000
Matched citations: S.4784
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including Issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
Consolidated Appropriations Act, 2026
2026 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Discussions regarding implementation of medtech related provisions for FY26 and FY27; H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.
Client expense: — · Firm income: $50,000
Matched citations: H.R.7148
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to R&D tax credit; Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including Issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Discussions related to the FY2025 budget reconciliation process and H.R.1, One Big Beautiful Bill Act (P.L.119-21), medical device related provisions.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to R&D tax credit; Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21).
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including Issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5343
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to R&D tax credit; Issues related to tax reform; One Big Beautiful Bill, H.R.1.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Discussions related to the FY2025 budget reconciliation process and One Big Beautiful Bill, H.R.1, medical device related provisions.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
2025 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Discussions related to the FY2025 budget reconciliation process and H.Con.Res.14, FY2025 Budget Resolution, medical device related provisions.
Client expense: — · Firm income: $50,000
Matched citations: H.Con.Res.14
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
General education to advance policies that support innovation in the medical device industry. Implementation of the Transitional Coverage for Emerging Technologies policies. H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1691
General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including H.R.2369 the VALID Act of 2023. Issues related to FDA regulation of medical devices. Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices. Issues related to PFAS Chemical regulation. Policy issues related to the regulation of artificial intelligence for medical technology. Legislative initiatives that could impact supply chain for medical technology.
Client expense: — · Firm income: $50,000
Matched citations: H.R.2369
Source: Senate LDA